Pterostilbene on metabolic parameters: a randomized, double-blind, and placebo-controlled trial.
Link to full study
Conclusion of this study
Pterostilbene increases LDL and reduces blood pressure in adults. This trial is registered with Clinicaltrials.gov NCT01267227.
Supplements analyzed in this study
Health conditions analyzed in this study
No health conditions information for this study.
Functions related to this study
Body systems related to this study